#ISC25 Late-Breaking Science oral abstracts
Get more information on these select Late-Breaking Science oral abstracts on Wednesday, Feb. 5, and Thursday, Feb. 6.
2-3 p.m. | Wednesday, Feb. 5 | Room 151
Volume of Brain Saved in Patients With a Medium Distal Vessel Occlusion Stroke Treated With Endovascular Therapy Plus Best Medical Treatment Versus Best Medical Treatment Alone: A Subanalysis of the DISTAL Trial
The SYCAMORE Study Results: First Randomized, Placebo-Controlled Phase 2 Trial in Symptomatic Cerebral Cavernous Malformation (CCM) Evaluating REC-994
Efficacy and Safety of Minocycline in Patients With Acute Ischemic Stroke (EMPHASIS): A Randomized Control Trial
Targeting Cerebral Amyloid Angiopathy at its Source: An Amyloid Beta Precursor Protein-Targeted siRNA Reduced Vascular Amyloid Beta and Hemorrhage in Rodent Models
9:15-10:45 a.m. |Thursday, Feb. 6 | Room 408AB
Clinical Benefit of Nerinetide at One Year in Early Window Participants Enrolled in ESCAPE-NEXT
Impact of Socioeconomic Status on Quality and Clinical Outcomes in Acute Ischemic Stroke Patients: Findings From Get With The Guidelines®-Stroke
More Severe Disruption of the Blood-Brain Barrier Predicts Greater Progression of Cerebral Small Vessel Disease
Efficacy of Otaplimastat in Acute Stroke Patients Requiring Reperfusion Therapy Standard of Care: A Pooled Analysis of Two Double-Blind, Randomized, Placebo-Controlled Studies
Stability of Flow Diverter Braids in INSPIRE-A: Biomechanical Predictors and Clinical Relevance
The Efficacy of Papaverine to Prevent Radial Artery Spasm During Transradial Cerebral Angiography (PASS): A Multicenter Randomized Trial
Results of the First Randomized Controlled Trial of Intravenous Alteplase Initiated Within 4.5 Hours of Central Retinal Artery Occlusion (CRAO): The THEIA Study
2-3 p.m. | Thursday, Feb. 6 | Room 502A
Efficacy and Safety of Intra-Arterial Thrombolysis Following Endovascular Reperfusion for Large-Vessel Occlusion Acute Ischemic Stroke: An Individual Patient Data Meta-Analysis of POST-UK and POST-TNK Randomized Trial
Glucagon-Like Peptide-1 Receptor Agonist in Large Vessel Occlusion Stroke Treated by Reperfusion Therapy: A Randomized Trial
Transauricular Vagus Nerve Stimulation Decreases Inflammatory Biomarkers and Affects NIHSS in Acute Ischemic Stroke Patients: Results From the NUVISTA Trial
Emergency Stroke Unit for Acute Cerebrovascular Events: A Multicenter, Alternating-Week, Randomized, Controlled Trial
2-3 p.m. | Thursday, Feb. 6 | Room 408AB
Updated Results From the Multicentric, Randomized Study of Sovateltide (Tycamzzi™) in Acute Cerebral Ischemic Stroke Patients
Comparative Effectiveness of Direct Oral Anticoagulants and Warfarin in Reduced Ejection Fraction After Stroke (CEDAR)
Dementia-Free Survival Differs by Midlife Blood Pressure and Genetic Risk Groups: The Atherosclerosis Risk in Communities (ARIC) Study
3:30-4:30 p.m. | Thursday, Feb. 6 | Room 502A
Rapid Administration of Enteral Nutrition Reduces Complications and Is Non-Inferior to Conventional Administration in Acute Stroke Patients: The Rapid EN Randomized Clinical Trial
Cerebral Blood Flow Response to Intrathecal Nicardipine is Associated With Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
Infarct Growth Rate and Tenecteplase Benefit in Ischemic Stroke at 4.5 to 24 Hours Without Thrombectomy: A Secondary Analysis of the TRACE-3 Trial
Spatio-Temporal Progression of Focal Ischemic White Matter Injury
4:45-5:45 p.m. | Thursday, Feb. 6 | Room 502A
Increase in Acute Ambient Particulate Matter Before Stroke Is Associated With Deterioration in Early Stroke Outcomes
Identification of Potential Neuroprotective Drug Targets for Ischemic Stroke From Genetic Insights: A Mendelian Randomization Study
The EMBOLISE Observation Study: Embolization of the Middle Meningeal Artery With ONYXTM Liquid Embolic System in the Treatment of Subacute and Chronic Subdural Hematoma
Central Nervous System Fibroblasts Mediate Extracellular Matrix Remodeling in Cerebral Amyloid Angiopathy
For more #ISC25 programming information, see the Online Program Planner.
